Life Tech Claims Victory in SOLiD-Related Patent Dispute with Illumina | GenomeWeb

Life Technologies’ subsidiary Applied Biosystems appears to have won a two-year legal quarrel with Illumina over three patents relating to ABI’s SOLiD sequencing technology.

Last week, during the second phase of a two-part trial in the US District Court for the Northern District of California, the jury decided that the SOLiD technology does not infringe the last patent at stake (see In Sequence 1/27/2009).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.